Detalles de la búsqueda
1.
Effect of indacaterol/glycopyrronium on ventilation and perfusion in COPD: a randomized trial.
Respir Res
; 23(1): 26, 2022 Feb 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-35144620
2.
Efficacy and safety of omalizumab in Chinese patients with anti-histamine refractory chronic spontaneous urticaria.
Dermatol Ther
; 35(4): e15303, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-34984792
3.
Efficacy and safety of omalizumab in patients with moderate-to-severe asthma: An analytic comparison of data from randomized controlled trials between Chinese and Caucasians.
Asian Pac J Allergy Immunol
; 40(3): 223-231, 2022 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-32247304
4.
Pregnancy outcomes in the omalizumab pregnancy registry and a disease-matched comparator cohort.
J Allergy Clin Immunol
; 145(2): 528-536.e1, 2020 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-31145939
5.
Capturing Exacerbations of Chronic Obstructive Pulmonary Disease with EXACT. A Subanalysis of FLAME.
Am J Respir Crit Care Med
; 199(1): 43-51, 2019 01 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30019939
6.
Indacaterol-Glycopyrronium versus Salmeterol-Fluticasone for COPD.
N Engl J Med
; 374(23): 2222-34, 2016 06 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-27181606
7.
Evaluation of exacerbations and blood eosinophils in UK and US COPD populations.
Respir Res
; 20(1): 178, 2019 Aug 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-31391053
8.
Treatment response to indacaterol/glycopyrronium versus salmeterol/fluticasone in exacerbating COPD patients by gender: a post-hoc analysis in the FLAME study.
Respir Res
; 20(1): 4, 2019 Jan 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-30621717
9.
Long-Term Triple Therapy De-escalation to Indacaterol/Glycopyrronium in Patients with Chronic Obstructive Pulmonary Disease (SUNSET): A Randomized, Double-Blind, Triple-Dummy Clinical Trial.
Am J Respir Crit Care Med
; 198(3): 329-339, 2018 08 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29779416
10.
Indacaterol/glycopyrronium versus salmeterol/fluticasone in the prevention of clinically important deterioration in COPD: results from the FLAME study.
Respir Res
; 19(1): 121, 2018 06 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-29925383
11.
Correlations between FEV1 and patient-reported outcomes: A pooled analysis of 23 clinical trials in patients with chronic obstructive pulmonary disease.
Pulm Pharmacol Ther
; 49: 11-19, 2018 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-29277690
12.
Blood Eosinophils and Response to Maintenance Chronic Obstructive Pulmonary Disease Treatment. Data from the FLAME Trial.
Am J Respir Crit Care Med
; 195(9): 1189-1197, 2017 05 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28278391
13.
Early Changes in eDiary COPD Symptoms Predict Clinically Relevant Treatment Response at 12 Weeks: Analysis from the CRYSTAL Study.
COPD
; 15(2): 185-191, 2018 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-29658810
14.
Dual Bronchodilation with Indacaterol Maleate/Glycopyrronium Bromide Compared with Umeclidinium Bromide/Vilanterol in Patients with Moderate-to-Severe COPD: Results from Two Randomized, Controlled, Cross-over Studies.
Lung
; 195(6): 739-747, 2017 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-28993871
15.
Response to Indacaterol/Glycopyrronium (IND/GLY) by Sex in Patients with COPD: A Pooled Analysis from the IGNITE Program.
COPD
; 14(4): 375-381, 2017 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-28594587
16.
Reply to Lan and Shi: Different Background, Short Duration, and Inappropriate Participants May Harm Your Conclusion.
Am J Respir Crit Care Med
; 199(3): 390-392, 2019 02 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30335471
17.
Reply to Cooper et al.: The Significance of Eosinophilic Inflammation in Chronic Obstructive Pulmonary Disease.
Am J Respir Crit Care Med
; 197(7): 968-969, 2018 04 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29140725
18.
Dual Bronchodilation Response by Exacerbation History and Eosinophilia in the FLAME Study.
Am J Respir Crit Care Med
; 197(9): 1223-1226, 2018 05 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29099609
19.
Reply: What Should Be the Cutoff Value of Blood Eosinophilia as a Predictor of Inhaled Corticosteroid Responsiveness in Patients with Chronic Obstructive Pulmonary Disease?
Am J Respir Crit Care Med
; 196(9): 1230-1231, 2017 11 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28650724
20.
Protocol design and synopsis: Omalizumab as Monotherapy and as Adjunct Therapy to Multiallergen OIT in Children and Adults with Food Allergy (OUtMATCH).
J Allergy Clin Immunol Glob
; 1(4): 225-232, 2022 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-37779534